Endoscope Reprocessing Market Size and Share Analysis by Product (High-Level Disinfectants & Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors, Endoscope Drying, Storage, & Transport Systems, Endoscope Tracking Solutions), Type (Flexible, Rigid), End User (Hospitals, Ambulatory Surgical Centers and Clinics) – Forecast to 2030

Market Overview

The global endoscope reprocessing market size stood at $1,879.9 million in 2021, which is expected to reach $4,358.1 million by 2030, advancing at a CAGR of 9.8% during 2021–2030. This is mainly ascribed to the rising inclination toward minimally invasive procedures, the promulgating risk of various infections associated with contaminated endoscopes, and the surging stringent government regulations spanning all over the world to regulate these infections.

High-Level Disinfectants and Test Strips Are the Highest Revenue Generator

The high-level disinfectants and test strips category accounted for around 35% of the market share in 2021, attributed to the rising prevalence of various endogenous infections, such as pneumonia and bacteremia, after the use of endoscopy procedures.

Similarly, the adoption of test strips is also increasing for the effective measurement of minimum effective concentration (MEC) required for high-level disinfection, thereby providing faster disinfection reaction time. In addition, it assists in the detection of residual proteins, carbohydrates, and hemoglobin on both flexible and rigid endoscopes, through the color comparison chart.

During the historical period, North America led the high-level disinfectants and test strips market, with around 50% revenue share in 2021. The region will account for the largest market share in the coming years as well, mainly due to the presence of a large number of high-level disinfectants and test strips manufacturers, stringent government regulations for keeping endoscopes sterilized after every use, high healthcare expenditure, and rise in the number of hospitals.

The automated endoscope reprocessor (AER) category is expected to register the highest CAGR, of around 12%, in the forecast period, owing to the rising number of endoscopic surgeries and the surging adoption of AERs in hospitals and ambulatory surgical centers. Moreover, companies are actively involved in launching innovative and advanced AERs in the market. For instance, in October 2020, Olympus Corporation launched OER-Elite AER for cleaning and reprocessing endoscopes. The OER-Elite can disinfect two endoscopes in less than 28 minutes.

In addition, several efforts put by government organizations to support the adoption of AERs in the region also enhance the endoscope reprocessing market growth. For instance, the FDA regulates all the critical factors that are necessary while reprocessing various endoscopes to mitigate the spread of infections. Also, as per the FDA guidelines, the AER manufacturers must provide validation testing data.

Endoscope Reprocessing Is Highly Implemented for Flexible Endoscopes

Endoscope reprocessing is predominantly used in flexible endoscopes, leading to a higher revenue share of around 65.0% in 2021 in the market. This is because prominent players in the market are actively launching AERs that are highly compatible with flexible endoscopes. For instance, approximately 90% of companies are developing AERs for flexible endoscopes, due to their feasibility to control and lighter weight. In October 2021, FUJIFILM Corporation announced the launch of the El-740D/S flexible endoscope, which is the only dual-channel flexible endoscope approved by the FDA for upper as well as lower gastrointestinal use.

Amongst the flexible type, upper gastrointestinal endoscopes and colonoscopes together account for more than 50% share in the market. This is ascribed to the promulgating incidents of GI as well colon diseases, leading to the rise in the number of hospital visits. For instance, around 40 million patients in the U.S. who visits physicians’ office are suffering from digestive system disorders.

Amongst the rigid type, laparoscopes accounted for more than 40% of the endoscope reprocessing market share in 2021, owing to the rising inclination toward minimally invasive procedures coupled with several benefits such as very few postoperative complications and faster recovery in comparison to open surgeries. These factors are leading to the high preference for laparoscopy alternatives to laparotomy. For instance, approximately 15 million laparoscopies are performed globally, every year.

Explore more about this report - Request free sample pages

Hospitals Category To Witness the Highest CAGR

The hospitals category is expected to record the highest CAGR, of around 11%, in the market during the forecast period. This can be attributed to the rising number of endoscopy procedures coupled with the increasing number of hospitals all over the world, and the promulgation of funds and investments provided by government bodies. For instance, the Indian government augmented its healthcare expenditure to around 1.8% of its GDP in 2021–2022, which was around 1.5% in 2020–2021.

Increasing Adoption of Comprehensive Contracts

End users in the market are becoming more inclined toward entering into comprehensive contracts with ISOs, in order to reduce complexities and additional expenses associated with separate services provided under agreements with manufacturers of medical equipment. For instance, NovaMed Corporation runs a comprehensive service management program that allows customers to consolidate the company’s services into one contract. The contract offers a cost-effective alternative to OEM contracts, coupled with multi-vendor, multi-modality access. Such examples affirm that the adoption of comprehensive endoscope service contracts is increasing.

Rising Preference for Minimally Invasive Procedures Driving North American Market

In 2021, North America accounted for the highest revenue, of around $1.0 billion, in the market. This is attributed to the rise in preference for minimally invasive procedures, spur in cancer cases, and favorable reimbursement scenarios in the region. Moreover, the presence of giant manufacturers of medical devices, such as Boston Scientific Corporation, Stryker Corporation, Conmed Corporation, and Cantel Medical Corp., leads to the easy availability of not only endoscopes but also OEM repair services.

• Texas led the U.S. market in 2021. Moreover, the state market is expected to witness the highest CAGR during 2021–2030. This will majorly be because of the high geriatric population in the state, combined with the high prevalence of cancer. Furthermore, the Texas Department of Aging and Disability Services (DADS), Employees Retirement System (ERS), Texas Department of State Health Services (DSHS), and Teacher Retirement System (TRS) account for around 83% of the healthcare spending in the state annually, which makes healthcare affordable for the masses. Therefore, the surging healthcare spending in the state is driving the demand for endoscopes, which, in turn, is boosting the market growth in Texas.

Whereas, the APAC market is expected to register the highest CAGR, over 10.0%, in the forecast period, due to the increase in the number of endoscopic surgeries and the improvement in healthcare infrastructure. Furthermore, Japan and China collectively accounted for around 50% share of the regional market in 2021. This is ascribed to the high incidence of GI-related cancers in both countries. For instance, as per a government organization, there were around 3,00,000 GI-related cancer deaths in China in 2021, which accounted for more than 13% of all cancer-related deaths in the nation.

Recent Strategic Developments of Key Players

In recent years, players in the endoscope reprocessing market have been involved in product launches and partnerships to attain a significant position. For instance, in September 2021, Steelco S.p.A announced the launch of EW 1 S MAXI, to increase safety, efficiency, and ease of use in the endoscope reprocessing practices.

Key Players in the Endoscope Reprocessing Market Are:

• Advanced Sterilization Products Inc.
• Olympus Corporation
• Ecolab Inc.
• STERIS
• Getinge AB
• Wassenburg Medical B.V.
• CONMED Corporation
• Belimed Inc.
• Cantel Medical Corp.

Market Size Breakdown by Segment

The study offers a comprehensive market segmentation analysis along with market estimation for the period 2017-2030.

Based on Product

• High-Level Disinfectants & Test Strips
• Detergents & Wipes
• Automated Endoscope Reprocessors
• Endoscope Drying, Storage, & Transport Systems
• Endoscope Tracking Solutions

Based on Type

• Flexible
  • Upper gastrointestinal endoscopes
  • Colonoscopes
  • Bronchoscopes
  • Sigmoidoscopes
  • Laryngoscopes
  • Duodenoscopes
  • Nasopharyngoscopes
  • Rhinoscopes
• Rigid
  • Laparoscopes
  • Ureteroscopes
  • Gynecology endoscopes
  • Arthroscopes
  • Cystoscopes
  • Neuroendoscopes

Based on End User

• Hospitals
• Ambulatory Surgical Centers and Clinics

Geographical Analysis

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
• Middle East and Africa
  • Saudi Arabia
  • South Africa